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Objective: To evaluate the reliability and validity of the im-
proved version of the Patient Generated Index (PGI) in pa-
tients with low back pain. 
Methods: The PGI was administered to 90 patients attending 
care in 1 of 6 institutions in Norway and evaluated for reli-
ability and validity. The questionnaire was given out to 61 
patients for re-test purposes. 
Results: The PGI was completed correctly by 80 (88.9%) 
patients and, of the 61 patients responding to the re-test, 
50 (82.0%) completed both surveys correctly. PGI scores 
were approximately normally distributed, with a median of 
40 (range 80), where 100 is the best possible quality of life. 
There were no floor or ceiling effects. The 5 most frequently 
listed areas affecting quality of life were pain, sleep, stiffness, 
socializing and housework. The test-retest intraclass corre-
lation coefficient was 0.73. The smallest detectable changes 
for individual and group purposes were 32.8 and 4.6, respec-
tively. The correlations between PGI scores and other instru-
ment scores followed a priori hypotheses of low to moderate 
correlations. 
Discussion: The PGI has evidence for reliability and valid-
ity in Norwegian patients with low back pain at the group 
level and may be considered for application in intervention 
studies when a comprehensive evaluation of quality of life is 
important. However, the smallest detectable change, of ap-
proximately 30 points, may be considered too large for indi-
vidual purposes in clinical applications. 
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IntRoductIon
Quality of life is widely recognized as an important outcome 
by patients, clinicians and researchers (1), and there has been 
considerable growth in the availability and application of 
instruments designed to measure health status and quality of 
life from the patient perspective (2, 3). However, relatively 
few instruments are available that assess quality of life relat-
ing to the impact of illness and dysfunction on the individual 
person or what are referred to as individualized quality of life 
instruments (2, 4). outcomes that are important to patients are 
not routinely measured (5, 6) and the inclusion of individual 
instruments when evaluating health interventions has been 
recommended (7). 
Whilst there is no universal definition of the term “quality 
of life” (8) there is broad agreement that it is individual and 
multidimensional (8). Standardized instruments have fixed 
domains and items and are often developed without patient 
involvement and hence may not cover areas of quality of life 
that are important to the patient. As a consequence they may 
have reduced content validity (4, 9). Individualized quality of 
life instruments have the advantage that the patient specifies 
areas of life that are important to them, which increase rel-
evance and content validity (4). used alongside standardized 
health status instruments, individualized instruments give a 
more complete assessment of quality of life. A recent study 
that included a review of patients’ perspective of recovery from 
low back pain (LBP) found that recovery is a highly individual, 
multidimensional and that domains such as fatigue, sleep, 
social function and emotional well-being are more important 
to patients’ than recognized in the literature (5). this study 
recommended the Patient Generated Index (PGI) for evaluating 
recovery from non-specific LBP alongside the existing core 
set of LBP outcome measures (5). 
the individualized approach to quality of life, as assessed by 
the PGI, may have more relevance to clinical decision-making 
and assessment than standardized patient-reported outcomes 
(PRos), which are usually based on the concerns of groups of 
patients and aspects of quality of life that they are assumed to 
share (4). Individualized approaches also offer an opportunity 
to evaluate concepts such as adjustment and response shift, 
which may be of pertinence in a rehabilitation context (10).
the PGI was developed in the uK in the early 1990s for 
different illness groups including LBP (11). It is based on the 
definition that quality of life is “the extent to which hopes 
and ambitions are matched by experience”, which has had 
previous application in health-related research (12, 13). the 
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PGI allows the patient to include areas of their life affected by 
their health problem that are important to them, together with 
a rating and importance weighting of these areas. the PGI has 
been evaluated and used in applications in several countries. 
However, the PGI has not been evaluated in patients with LBP 
since its development in the 1990s and it has not been evalu-
ated in patients with LBP in norway. Following a review of 
its psychometric properties it was concluded that the instru-
ment has acceptable levels of reliability and had evidence for 
validity across different studies (14) and more recent versions 
of the PGI have been developed to improve acceptability and 
completion rates (14, 15). the PGI used in the current study 
is the latest available version, which is based on findings from 
previous studies including patient interviews to assess accept-
ability (16, 17), has an improved design and shorter scale in 
stage 2 and fewer points to distribute in stage 3. the study 
objective was to evaluate the reliability and validity of the 
latest version of the PGI in patients with LBP.
MEtHods
Design
the PGI was administered by means of a self-completed questionnaire 
to 90 patients with non-specific LBP receiving care in 1 of 6 treatment 
facilities in oslo, norway over one year from september 2008. these 
included 3 physiotherapy clinics, 1 outpatient rehabilitation clinic, 1 
pain clinic and 1 orthopaedic department. within 1 week following 
their inclusion at the institutions, patients were given a second PGI 
for the purpose of assessing test-retest reliability. the data collection 
procedures at the individual institutions meant that information on the 
total number of eligible patients asked to participate was unavailable. 
data collection followed recommendations for sample sizes proposed 
for methodological studies including reliability and validity, suggesting 
that at least 50 patients are necessary to test for construct validity and 
test-retest reliability and agreement (18, 19).
Participants and ethics
The inclusion criteria were: patients with non-specific LBP, aged ≥18 
years old and acceptable Norwegian. Exclusion criteria were sciatica or 
signs of “red flags” (20). The clinician asked patients fulfilling the inclu-
sion criteria whether they would be willing to participate in the study and 
those agreeing gave written informed consent. the study was approved 
by the norwegian Regional committee for Medical Research Ethics 
and the data Inspectorate and followed the declaration of Helsinki.
Patient-reported outcomes
the baseline questionnaire included the PGI and other measures 
of health status that were used for the purposes of testing construct 
validity. The PGI is completed in 3 stages. In the first stage, patients 
are asked to list up to 5 important areas in their life affected by their 
LBP. The second stage asks patients to rate the extent to which their 
LBP has affected them in each area and in the rest of their lives on a 
7-point scale, from “the worst they can imagine” to “exactly as they 
would like it to be”. the third stage asks patients to imagine that they 
can improve some or all of the areas. they have 10 points to distribute 
across the areas that they would most like to improve. the overall 
score from 0 to 100, representing the worst and best possible quality 
of life, respectively, is computed as follows: [Σ (area score × points 
spend /10)]/6 × 100 (21).
An example of the 3 stages in the completion of the PGI for pa-
tients with LBP is given in Appendix I. Following recommendations, 
different colours were used to separate the stages of the PGI that are 
intended to aid completion (17).
the PGI has been translated into norwegian following recommended 
criteria (22). A trigger list of areas considered important for patients 
with LBP was included. The list was based on previous findings for 
patients with musculoskeletal disorders (11, 15, 22) and discussion 
in an expert panel. A closed format of the PGI was used in this study, 
where baseline areas are included at follow-up.
the other instruments included the EuroQol-5d (EQ-5d) (23), which 
is a generic utility instrument with 5 items that have 3-point descriptive 
scales of no problem, some problems and severe problems. the EQ-5d 
index is based on utility weights from the general population and is 
scored from –0.59 to 1.0, where 1 is the best possible score. the EQ-5d 
has evidence for reliability and validity in norwegian LBP patients (24). 
Disability in daily activities was assessed by the back-specific 
Roland Morris disability Questionnaire (RMdQ), which has 24 yes/
no items that sum to a score from 0 to 24, where 24 is the most severe 
disability (25). the RMdQ has evidence for reliability and validity 
in norwegian LBP patients (26).
Psychological distress was assessed by the Hopkin’s symptom 
check List (HscL-25), which comprises 25 items relating to psycho-
logical distress (27). the HscL-25 asks about symptoms complaints 
during the last week and items have a 4-point scale, from “not at all” 
to “to a large extent”. The items sum to give a score from 0 to 4, where 
4 is the most severe symptoms. the norwegian HscL-25 version has 
been used in several studies (28, 29).
Illness perceptions was assessed by the Brief Illness Perceptions 
Questionnaire (Brief IPQ) (30) which has 9 items comprising cogni-
tive and emotional illness perceptions. the items have a 0–10 scale 
with end-point descriptors. the overall score from 0 to 10, represents 
the degree to which the illness is perceived as threatening or benign. 
Higher scores represent a more threatening view of the illness. the 
instrument has evidence for reliability and validity (30). 
Pain catastrophizing was assessed by the 13-item Pain catastrophiz-
ing Scale (PCS) (31), which asks about past painful experiences and 
the degree to which they were experienced, on a 5-point scale from 
“not at all” to “all the time” (31). PCS total scores range from 0 to 52, 
where 52 is the highest level of catastrophizing. the Pcs has evidence 
for reliability and validity in norwegian patients with LBP (32). 
Fear avoidance was assessed by the Fear Avoidance Beliefs Ques-
tionnaire (FABQ) (33), which comprises 16 items that give 2 subscales 
of fear avoidance for work (FABQ-w) and fear avoidance beliefs for 
physical activity (FABQ-PA). the items have a 7-point scale from 
“completely disagree” to “completely agree”. Scale scores range from 
0 to 42 for the FABQ-w and 0–24 for the FABQ-PA, where higher 
scores represent greater fear avoidance beliefs. the questionnaire has 
been evaluated in patients with LBP in norway (34).
Finally, the questionnaire included a 10-point numeric rating scale 
measuring pain and questions relating to duration of LBP, age, gender 
and employment. the test-retest questionnaire included a health transi-
tion item asking about change in LBP since baseline with a 6-point 
descriptive scale from “worse” to “completely recovered”. 
Statistical analysis
the consensus-based standards for the selection of health Measure-
ment Instruments (cosMIn) checklist for measurement properties 
of health status questionnaires informed instrument evaluation in-
cluding sample size, reliability, agreement and validity (18, 35). the 
PGI was assessed for levels of missing data and floor/ceiling effects 
were considered present if more than 15% of the respondents had the 
highest or lowest possible score (18). the test-retest reliability of the 
PGI score was assessed by intraclass correlation (Icc) 2.1, which 
should exceed the criterion of 0.7 for use in groups of patients (18). 
the standard error of measurement (sEM) and the smallest detect-
able change (sdc) were used to assess agreement in accordance with 
published recommendations. sEM was calculated by taking the square 
root of the error variance of an analysis of variance (AnovA) analysis. 
the sdcindividual is equal to 1.96 × √2 × SEM and reflects the smallest 
within-person change in score that with p < 0.05 can be interpreted 
as “real change”, above measurement error. The SDCgroup is equal to 
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sdcindividual divided by √ n (18). Limits of agreement (Bland and Alt-
man plot) were performed as an additional parameter of agreement 
(mean difference test-retest against mean test-retest scores). Limits of 
agreement lines were drawn at đ +/– 1.96 × SDdifference (18).
construct validity was assessed by comparing the baseline PGI 
scores with those for the other instruments based on a priori hypotheses 
derived from a structured literature review of PGI and related variables 
(11, 14, 15). It was expected that PGI scores would be positively as-
sociated with physical and social functioning and psychological well-
being. Moderate to high correlations were expected between the PGI 
scores and numeric Rating scale (nRs) pain and RMdQ. Moderate 
to high correlations were expected with EQ-5D scores, which measure 
general health status. Low to moderate correlations were expected 
with instrument scores relating to beliefs and aspects of psychological 
well-being, including the HscL-25, Brief IPQ, Pcs and FABQ. Given 
the condition-specific focus of the PGI, it was further hypothesized 
that correlations would be generally higher for the specific instruments 
with the exception of the FABQ, which assesses specific beliefs. 
spearman’s rho was used for correlations because not all data were 
normally distributed. correlations below 0.3, 0.3 to 0.6 and over 0.6 
were considered low, moderate and high, respectively (36).
sPss version 18 was used for statistical analysis.
REsuLts
Participation 
the study included 90 patients, the majority of whom were 
attending primary care (33%) or an orthopaedic hospital de-
partment (33%). Most of the patients reported having chronic 
LBP (78.9%); 57.8% were female and mean age was 47.6 (sd 
11.8) years (table I). 
Completion of the PGI
the PGI was correctly completed by 80 (88.9%) patients who 
returned a questionnaire. No statistical significant differences 
were found between patients with correct or incorrect com-
pletion in relation to clinical setting, duration of back pain, 
age, gender, and employment status. the PGI scores were ap-
proximately normally distributed with a median of 40 (range 
80), where 100 is the best quality of life. There were no floor 
or ceiling effects. 
The 384 areas chosen in stage 1 of the PGI could be classified 
into 20 categories, of which 90% were found in the trigger list 
(Fig. 1). the most frequently listed areas for the 86 patients 
Fig. 1. Classification of the 384 areas given in stage 1 of the Patient Generated Index (PGI) (n = 86).
table I. Patient characteristics at baseline and test-retest
variables
Baseline
n = 90
test-retest
n = 61
Recruited from, n (%)
Primary healthcare 30 (33.3) 14 (23.0)
outpatient rehabilitation clinic 24 (26.7) 22 (36.1)
orthopaedic hospital department 30 (33.3) 21 (34.4)
Pain clinic hospital 6 (6.7) 4 (6.6)
duration current episode, n (%)
0–6 weeks 11 (12.2) 8 (13.1)
7–12 weeks 8 (8.9) 3 (4.9)
> 3 months 71 (78.9) 5 (82.0)
EQ-5da, median (range) 0.7 (1.2) 0.7 (1.0)
RMdQb, median (range) 7.0 (24) 7.0 (24)
HscL-25c, median (range) 1.5 (2.0) 1.5 (2.0)
FABQd, median (range)
Physical activity 9.0 (22) 9.0 (22)
work 15.0 (42) 15.5 (42)
Back pain (nRs)e, median (range) 5 (8) 5 (8)
Sex, n (%)
Male 38 (42.2) 29 (47.5)
Female 52 (57.8) 32 (52.5)
Age years, mean (sd) 47.6 (11.8) 49.2 (11.2)
Employment status, n (%)
Employed 41 (45.6) 25 (41.0)
not employed/sick leave 24 (26.7) 18 (29.5)
Pension 25 (27.8) 18 (29.5)
aEuroQuol-5d (EQ-5d) (–0.59 to 1.0). Higher score represent better 
health-related quality of life.
bRoland Morris disability Questionnaire (RMdQ) (0–24). Higher score 
represent greater overall disability.
cHopkin’s symptom check List (HscL-25) (1–4). Higher scores represent 
more severe symptoms.
dFear Avoidance Beliefs Questionnaire (FABQ) physical activity 
(0–24). FABQ work (0–42). Higher scores represent increased levels of 
fear avoidance beliefs.
enumeric Rating scale (nRs) (0–10). Higher scores represent more pain.
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completing stage 1 of the PGI were pain (65%), sleep (47%), 
stiffness (34%), socializing (34%) and housework (33%). 
Test-retest reliability
the time interval between test and return of the re-test PGI 
ranged from 1 to 31 days, with a median of 7 days. of the 
61 patients responding to the re-test, 50 (82.0%) completed 
both administrations correctly (table II). the Icc was 0.73 
(95% cI 0.52–0.84). the sEM was 11.8 and the sdcindividual 
and sdcgroup were 32.8 and 4.6, respectively. similar results 
were found for those patients who reported “no change” at 
the re-test assessment (table II). the limits of agreement are 
presented in Fig. 2.
Construct validity
the results of the correlations between the PGI scores and those 
for the other instruments supported all the a priori hypotheses. 
there were moderate correlations in the range –0.39 to –0.45 
between the PGI and the scores for the EQ-5d, RMdQ, nRs 
pain, HscL-25 and Brief IPQ. Low correlations were found 
for the Pcs and FABQ scores (table III). 
dIscussIon
this study evaluated the reliability and validity of the PGI for 
patients with LBP and is the first to do so since the PGI was de-
veloped in the early 1990s. the PGI was recently recommended 
as a standardized measure of recovery from non-specific LBP 
(5) and the current study shows that the PGI is acceptable to 
this patient group. 
Approximately 90% of the respondents completed the PGI 
correctly at baseline. this represents a considerable improve-
ment from the first evaluation of the PGI in patients with LBP, 
acknowledging differences in the study design and setting of 
table II. Median (range) at baseline and re-test and agreement for all patients (n = 50), for patients reporting “no change” (n = 27) and for patients 
reporting a re-test period under two weeks (n = 41)
Baseline
Median (range)
Re-test
Median (range) sEMb sdcindividualc sdcgroupd Icce (95% cI)
PGI scoresa (n = 50) 42.50 (80) 49.17 (83.33) 11.83 32.77 4.64 0.73 (0.52–0.84)
PGI scores (n = 27) 43.33 (78.33) 46.67 (76.67) 11.43 31.66 6.09 0.72 (0.40–0.87)
PGI scores (n = 41) 41.67 (68.33) 48.33 (83.33) 10.56 29.25 4.57 0.76 (0.54–0.87)
aPatient Generated Index (PGI) scores 0–100: overall score of PGI. A higher score reflects better quality of life.
bstandard error of measurement (SEM) agreement: √within people residual mean square.
cSmallest detectable change (SDC) individual: (√within people residual mean square) × 2.77.
dSDC group: (SDC individual/√n).
eIntraclass correlation (Icc) agreement: 2-way random effects model (absolute agreement).
CI: confidence interval; SD: standard deviation.
Fig. 2. Limits of agreement (n = 50). the solid and the dotted lines represent the mean and the mean ± 1.96 standard deviation (sd), respectively. PGI: 
Patient Generated Index.
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the 2 studies (11). More recently, studies evaluating the PGI 
in patients with rheumatic diseases with a comparable version 
of the PGI reported similar results (15, 22) and these results 
compare favourably with those for other studies (11, 37). the 
higher completion rates may be due to greater acceptability 
to patients following the use of a shorter scale in stage 2 and 
fewer points in stage 3. In addition, the different colours used 
to separate the stages may have improved completion (17). 
However, the completion was still lower than for the 
standardized instruments. Interviews or focus groups with 
patients that are designed to address issues of completion may 
contribute to further improvements in the acceptability of the 
PGI. other means of completion may be necessary to achieve 
similar rates to those of standardized instruments. Electronic 
administration offers scope for tailoring the instructions of the 
PGI to those of the individual patient, which may make the 
use of such instruments more feasible in future applications. 
the Icc was acceptable and the results are similar to pre-
vious evaluations. However, a few studies using the same or 
comparable formats have reported Iccs above 0.8 (15, 22). 
It is possible that the ICC in this study was influenced by the 
duration between test and re-test, which ranged from 1 to 31 
days with a median of 7 days. there has been some discussion 
relating to the most appropriate length of the period between 
test and re-test; however, several authors agree that approxi-
mately 2 weeks is acceptable (38). In this study, 10 patients 
had a test-retest period longer than 2 weeks, which may be 
considered too long, as some of these patients were under 
treatment (8). However, as table II shows, this did not seem 
to influence the test-retest results. 
the agreement results, including sEM and sdc, indicated 
that a change of above approximately 30 points at an indi-
vidual level and 5 points at group level on the 0–100 scale 
are necessary to preclude measurement error. These findings 
are comparable to other PRo instruments, such as the short 
Form (36) Health survey (sF-36) in patients with LBP (39). 
A sdc estimate of 30 points might be considered too large 
for clinical application on an individual basis. we are aware 
of only one other study reporting sdc for the PGI (22), which 
found an sdcindividual of 20 in patients with rheumatic diseases, 
with a test-retest interval of approximately 1–2 days. Again, it 
is possible that the test-retest period may have influenced the 
results and a shorter period is recommended in future studies. 
the authors of a review of the PGI concluded that construct 
validity has generally been reported as acceptable (14). our 
results are comparable with those of other studies, including 
studies of patients with musculoskeletal disorders that have 
reported moderate levels of correlation with comparable instru-
ments such as the EQ-5d, nRs pain and sF-36 (15, 22, 40). 
Slightly higher correlations were found with disease-specific 
instrument scores, which follows previous findings (15). The 
lowest correlations were with the scores for instruments 
measuring pain catastrophizing and fear-avoidance, which 
relate more generally to specific aspects of beliefs rather than 
health or quality of life. the evaluations of structural validity 
using factor analysis and modern psychometric methods are 
not possible for the PGI, since each patient nominates their 
own areas creating an individualized item pool.
Patients choose areas of importance to them, which lends 
the PGI content validity from the perspective of the individual 
patient at the time of completion. Among the 5 most impor-
tant areas of life affected by LBP were pain, sleep and social 
life. these areas are known to be important to patients with 
LBP, and are included in the proposal for standardized use of 
back-specific outcome measures, such as the RMDQ and the 
Oswestry LBP Disability Index (ODI) (41). However, many 
of the areas mentioned by patients as important, including 
stiffness, work, exercise, social relations and psychological 
well-being, are not covered by standardized outcome measures 
commonly applied in LBP research. Although standardized 
instruments developed with patient involvement include im-
portant areas for the majority of patients, these findings lend 
support to the argument that individualized instruments, such 
as the PGI, have the advantage of capturing what is relevant to 
the individual patient by eliciting important additional concerns 
and priorities. These findings are supported by a qualitative 
study of recovery from LBP, which found that additional areas 
were identified as more important to patients than previously 
recognized (42). Moreover, standardized outcome measures 
assess outcomes across a number of scale scores. this creates 
difficulties for researchers and practitioners who must consider 
different instrument scores and their importance as measures 
of outcome. the PGI, through its inclusion of areas of greatest 
importance, as defined and rated by patients, gives a single 
score that circumvents this problem, and hence is simpler to 
use in research and clinical applications. over 4% of patients 
table III. Correlation between the Patient Generated Index (PGI) and EQ-
5D, RMDQ, NRS pain, HSCL-25, Brief IPQ, PCS and FABQ scores (n=80) 
PGI instrument
correlation 
coefficient
EQ-5da 0.40*
RMdQb –0.45*
nRs painc –0.43*
HscL-25d –0.39*
Brief IPQe –0.45*
Pcsf –0.17
FABQ Pg –0.20
FABQ w –0.23
*p < 0.001 level.
aEuroQuol-5d (EQ-5d) (–0.59 to 1.0). Higher scores represent better 
health-related quality of life.
bRoland Morris disability Questionnaire (RMdQ) (0–24). Higher scores 
represent greater overall disability.
cnumeric Rating scale (nRs) (0–10). Higher scores represent more pain.
dHopkin’s symptom check List (HscL-25) (1–4). Higher scores represent 
more severe symptoms.
ethe Brief Illness Perceptions Questionnaire (Brief IPQ) (0–10). Higher 
scores represent more threatening or benign illness perceptions.
fPain catastrophizing scale (Pcs) (0–52) Higher scores represent higher 
levels of catastrophizing.
gFear Avoidance Beliefs Questionnaire (FABQ) physical activity (0–24), 
FABQ work (0–42). Higher scores represent increased levels of fear 
avoidance beliefs.
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mentioned exercise or physical activity as an important area in 
their lives. these areas were not part of the trigger list in this 
study but, because they are important to patients, they should 
be considered for future inclusion in the list.
there are a number of instruments available that include 
individualized content or weightings for areas (2). the Measure 
Yourself Medical Outcome Profile (MYMOP) has been adapted 
from the PGI and aims to assess the outcomes that the patient 
considers the most important by asking the patient to choose 
one or two symptoms and one activity that is limited because of 
health problem(s) (43). Parts of the MyMoP are recommended 
for completion as part of the clinical consultation. the sEIQoL 
is similar to the PGI, in that completion involves the listing of 
important areas and scoring them (44). However, the sEIQoL 
assesses overall quality of life rather than quality of life related 
to a specific health problem. The PGI was considered a more 
appropriate self-report instrument for assessing quality of life 
relating to specific diseases and health status, including LBP. 
Moreover, the PGI has been previously evaluated in patients 
with back pain (11, 40). 
Study limitations
the lack of data available from the institutions meant that it 
was not possible to assess the overall response rate, which is 
the main weakness of the study. the clinicians were asked 
how many patients they had given the questionnaire; however, 
this information was not seen as completely reliable, as some 
did not have specific routines for registering all patients they 
considered for inclusion. Previous studies with the PGI have 
found acceptable overall response rates for self-completed 
postal questionnaires that included multiple instruments to 
assess health status and quality of life (11, 40). Hence, there 
is no reason to believe that inclusion of the PGI leads to lower 
overall response rates to this form of self-administered ques-
tionnaire. Another potential limitation may be that the time 
interval between test and re-test questionnaires was too long 
for some patients, although the median was 7 days, which is 
considered acceptable (45). some patients were under treat-
ment, and this limitation may have given poorer reliability 
estimates than those from a more appropriate design. 
Conclusion
the present study shows that the PGI is appropriate for assessing 
individualized quality of life in patients with LBP. the PGI has 
evidence for acceptability, reliability and validity at the group 
level and should be considered for application in intervention 
studies alongside other measures of quality of life when a com-
prehensive evaluation of quality of life is important. However, 
the SDC of approximately 30 points may be considered too large 
for individual purposes in clinical applications. 
AcKnowLEdGEMEnts
this project was funded by the Research council of norway.
we thank the patients participating in this study. we also want to thank 
the following institutions involved in the data collection: nIMI/Hjelp 24, 
ullevål stadium, oslo university Hospital Rikshospitalet, Aker Hospital, 
Friskvernklinikken Asker, stadion Physiotherapy clinic and Hans & olaf 
Physiotherapy.
The authors declare no conflicts of interest.
REFEREncEs
1. woolf Ad. the bone and joint decade 2000–2010. Ann Rheum 
dis 2000; 59: 81–82.
2. Garratt A, schmidt L, Mackintosh A, Fitzpatrick R. Quality of 
life measurement: bibliographic study of patient assessed health 
outcome measures. BMJ 2002; 324: 1417.
3. Garratt A. Patient reported outcome measures in trials. BMJ 2009; 
338: a2597.
4. carr AJ, Higginson IJ. Are quality of life measures patient centred? 
BMJ 2001; 2: 1357–1360.
5. Hush JM, Kamper sJ, stanton tR, ostelo R, Refshauge KM. 
Standardized measurement of recovery from nonspecific back 
pain. Arch Phys Med Rehabil 2012; 93: 849–855.
6. Hewlett s, carr M, Ryan s, Kirwan J, Richards P, carr A, et al. 
outcomes generated by patients with rheumatoid arthritis: how 
important are they? Musculoskeletal care 2005; 3: 131–142.
7. sanderson t, Kirwan J. Patient-reported outcomes for arthritis: 
time to focus on personal life impact measures? Arthritis Rheum 
2009; 15: 1–3.
8. Fayers PM, Machin d. Quality of life. the assessment, analysis 
and interpretation of patient- reported outcomes. 2nd ed. chich-
ester: wiley; 2007. 
9. Gill tM, Feinstein AR. A critical appraisal of the quality of quality-
of-life measurements. JAMA 1994; 272: 619–626.
10. dijkers MP. Individualization in quality of life measurement: 
instruments and approaches. Arch Phys Med Rehabil 2003; 84: 
s3–s14.
11. Ruta dA, Garratt AM, Leng M, Russell It, Macdonald LM. A 
new approach to the measurement of quality of life. the Patient-
Generated Index. Med Care 1994; 32: 1109–1126.
12. Garratt AM, Ruta D. The Patient Generated Index. In: O’Boyle 
cA, McGee H, Joyce cRB, editors. Individualised quality of 
life. Approaches to conceptualisation and assessment. Reading: 
Harwood Academic; 1999, p. 105–118.
13. calman Kc. Quality of life in cancer patients – an hypothesis. J 
Med Ethics 1984; 10: 124–127.
14. Martin F, Camfield L, Rodham K, Kliempt P, Ruta D. Twelve years’ 
experience with the Patient Generated Index (PGI) of quality of 
life: a graded structured review. Qual Life Res 2007; 16: 705–715.
15. Haywood KL, Garratt AM, dziedzic K, dawes Pt. Patient centered 
assessment of ankylosing spondylitis-specific health related quality 
of life: evaluation of the Patient Generated Index. J Rheumatol 
2003; 30: 764–773.
16. Camfield L, Ruta D. ‘Translation is not enough’: using the Global 
Person Generated Index. Qual Life Res 2007; 16: 1039–1051.
17. tavernier ss, totten AM, Beck sL. Assessing content validity 
of the patient generated index using cognitive interviews. Qual 
Health Res 2011; 21: 1729–1738.
18. terwee cB, Bot sd, de Boer MR, van der windt dA, Knol dL, 
dekker J, et al. Quality criteria were proposed for measurement 
properties of health status questionnaires. J clin Epidemiol 2007; 
60: 34–42.
19. Altman dG. Practical statistics for medical research. London: 
chapman & Hall; 1991.
20. Lærum E, Brox JI, Storheim K. [Low Back Pain- With and with-
out sciatica. national clinical Guidelines.] oslo: FoRMI; 2007 
(in norwegian). 
21. tavernier ss, Beck sL, clayton MF, Pett MA, Berry dL. valid-
ity of the Patient Generated Index as a quality-of-life measure 
in Radiation oncology. oncol nurs Forum 2011; 38: 319–329.
J Rehabil Med 46
787Evaluation of the Patient Generated Index
22. Klokkerud M, Grotle M, Loechting I, Kjeken I, Hagen KB, Gar-
ratt AM. Psychometric properties of the norwegian version of 
the Patient Genereated Index in patients with rheumatic diseases 
participating in rehabilitation or self-management programs. Rheu-
matology (Oxford) 2013; 52: 924–932.
23. the EuroQol Group. EuroQol – a new facility for the measurement 
of health-related quality of life. Health Policy 1990; 16: 199–208.
24. solberg tK, olsen JA, Ingebrigtsen t, Hofoss d, nygaard Ø P. 
Health-related quality of life assessment by the EuroQol-5d can 
provide cost-utility data in the field of low-back surgery. Eur Spine 
J 2005; 14: 1000–1007.
25. Roland M, Fairbank J. the Roland-Morris disability Question-
naire and the oswestry disability Questionnaire. spine 2000; 25: 
3115–3124.
26. Grotle M, Brox JI, Vollestad NK. Cross-cultural adaptation of the 
norwegian versions of the Roland-Morris disability Question-
naire and the Oswestry Disability Index. J Rehabil Med 2003; 
35: 241–247.
27. derogatis LR, Lipman Rs, Rickels K, uhlenhuth EH, covi L. 
the Hopkins symptom checklist (HscL): a self-report symptom 
inventory. Behav sci 1974; 19: 1–15.
28. Hagen KB, Magnus P, vetlesen K. neck/shoulder and low-back dis-
orders in the forestry industry: relationship to work tasks and per-
ceived psychosocial job stress. Ergonomics 1998; 41: 1510–1518.
29. Haldorsen EMH, Indahl A, ursin H. Patients with low back pain 
not returning to work: a 12-month follow-up study. spine 1998; 
23: 1202–1208.
30. Broadbent E, Petrie KJ, Main J, weinman J. the brief illness 
perception questionnaire. J Psychosom Res 2006; 60: 631–637.
31. sullivan MJL, Bishop sP, Pivik J. the Pain catastrophizing scale: 
development and validation. Psychological assessment 1995; 7: 
524–532.
32. Fernandes L, storheim K, Lochting I, Grotle M. cross-cultural 
adaption and validation of the norwegian pain catastrophizing 
scale in patients with low back pain. BMc Musculoskelet disord 
2012; 13: 111.
33. waddell G, newton M, Henderson I, somerville d, Main cJ. A 
Fear-Avoidance Beliefs Questionnaire (FABQ) and the role of 
fear-avoidance beliefs in chronic low back pain and disability. 
Pain 1993; 52: 157–168.
34. Grotle M, Brox JI, Vollestad NK. Reliability, validity and respon-
siveness of the fear-avoidance beliefs questionnaire: methodological 
aspects of the norwegian version. J Rehabil Med 2006; 38: 346–353.
35. Mokkink LB, terwee cB, Patrick dL, Alonso J, stratford Pw, Knol 
dL, et al. the cosMIn checklist for assessing the methodologi-
cal quality of studies on measurement properties of health status 
measurement instruments: an international delphi study. Qual Life 
Res 2010; 19: 539–549.
36. Andresen EM. criteria for assessing the tools of disability out-
comes research. Arch Phys Med Rehabil 2000; 81: s15–s20.
37. Tully M, Cantrill J. The test-retest reliability of the modified Pa-
tient Generated Index. J Health Serv Res Policy 2002; 7: 81–89.
38. de vet Hc, terwee cB, Mokkink LB, Knol dL. Measurement in 
medicine. cambridge: cambridge university Press; 2011.
39. Davidson M, Keating JL. A comparison of five low back pain 
disability questionnaires: reliability and responsiveness. Physical 
therapy 2002; 82: 8–24.
40. Ruta dA, Garratt AM, Russell It. Patient centred assessment of 
quality of life for patients with four common conditions. Qual 
Health care 1999; 8: 22–29.
41. deyo RA, Battie M, Beurskens AJ, Bombardier c, croft P, Koes 
B, et al. outcome measures for low back pain research. A proposal 
for standardized use. spine 1998; 23: 2003–2013.
42. Hush JM, Refshauge K, sullivan G, de sL, Maher cG, McAuley 
JH. Recovery: what does this mean to patients with low back pain? 
Arthritis Rheum 2009; 61: 124–131.
43. Paterson c. Measuring outcomes in primary care: a patient gener-
ated measure, MyMoP, compared with the sF-36 health survey. 
BMJ 1996; 312: 1016–1020.
44. McGee HM, o’Boyle cA, Hickey A, o’Malley K, Joyce cR. 
Assessing the quality of life of the individual: the sEIQoL with 
a health and a gastroenterology unit population. Psychol Med 
1991; 21: 749–759.
45. streiner dL, norman GR. Health measurement scales. A practi-
cal guide to their development and use. 4th ed. Oxford: Oxford 
university Press; 2008.
APPENDIX I. The 3 stages in the completion of the Patient Generated Index (PGI) for patients with low back pain
stage 1: Area affected  stage 2: score area 0–6 stage 3: distribute 10 points total 
1.  work 2 × 4/10 = 0.8
2.  Play with my children 3 × 4/10 = 1.2
3.  Hobby 2 × 0/10 = 0
4.  Exercise 2 × 0/10 = 0
5.  sleep 3 × 1/10 = 0.3
6.  All other areas affected by your low back pain 3 × 1/10 = 0.3
PGI sum scorea 2.6/6 × 100 = 43.3
aPGI sum score = [ Σ (area score × points spend /10) ] / 6 × 100.
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